Bitcoin price today: rises above $111k amid easing trade jitters; US CPI on tap
ENDRA Life Sciences Inc. (NDRA) completed a private placement that raised approximately $4.9 million in gross proceeds, with potential for up to $9.5 million more from future warrant exercises, according to a company statement.
The medical imaging technology company simultaneously purchased 78,863.1 HYPE tokens valued at approximately $3 million as of October 21, 2025, marking the launch of its digital asset treasury strategy. HYPE operates in the decentralized perpetual futures ecosystem.
The private investment in public equity financing was led by institutional and cryptocurrency investors, with Lucid Capital Markets serving as the sole placement agent.
"This marks a foundational step in our long-term digital asset treasury strategy," said Alexander Tokman, CEO of ENDRA Life Sciences . "By aligning with Arca’s most strategic positions in DeFi, we are not just preserving capital – we are actively putting it to work in some of the most innovative and yield-generating digital asset ecosystems in the world."
ENDRA develops Thermo Acoustic Enhanced UltraSound technology for assessing tissue fat content and monitoring liver conditions. The company stated its digital asset strategy focuses on holdings recommended by Arca Investment Management and includes techniques such as options overlays, staking, and DeFi participation.
The company said the strategy aims to grow tokens-per-share, generate income for reinvestment, and create opportunities for cryptocurrency-related mergers and acquisitions.